Conflict of interest declaration: John C Ruckdeschel

Roles in: Lung Cancer Group

1. In the past three years have you accepted the following from an organisation that may gain or lose financially from the publication of reviews by your review group in the Cochrane Database of Systematic Reviews (CDSR)?

a) Reimbursement for attending a conference or symposium (including travel, accommodation and/or hospitality)?
No

b) Fees for speaking?
No

c) Fees for organising education?
No

d) Funds for research?
No

e) Funds for a member of staff?
No

f) Fees for consulting?
Yes - CONSULTANT FOR PRO-LUNG WHICH MAKES A BIO-CONDUCTANCE DEVICE FOR ASSESSING PULMONARY NODULES AND EMX INTERNATIONAL WHICH IS DEVELOPING A BREATH ANALYSIS DEVICE FOR EARLY DETECTION CONSULTED ONCE 2 YEARS AGO FOR MYRIAD DIAGNOSTICS ON USE OF MOLECULAR PANEL FOR LUNG CANCER DIAGNOSIS CONSULT FOR GENYOUS-OMNITURA WHICH IS DEVELOPING A NEW CLASS OF COMPOUNDS THAT MAY ULTIMATELY BE USED IN LUNG CANCER

g) Royalty payments?
No

2. In the past three years have you or your spouse/partner been employed by an organization that may in any way gain or lose financially from the publication of reviews by your review group in the CDSR?
No

3. Do you own stocks or shares in companies that may gain or lose financially from the publication of reviews by your review group in the CDSR?
Yes - I OWN SHARES IN PRO LUNG, EMX INTERNATIONAL AND GENYOUS OMNITURA. SEE ABOVE

4. Do you hold any patents for products that that may lead you to gain or lose financially from the publication of reviews by your review group in the CDSR?
No

5. Do you have any other competing interests (financial or non-financial)?
No